Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
Authors
Keywords
-
Journal
PATHOLOGY INTERNATIONAL
Volume 62, Issue 11, Pages 735-741
Publisher
Wiley
Online
2012-11-02
DOI
10.1111/pin.12001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells
- (2012) Xiaomin Dang et al. Cancer Genetics
- The role of EZH2 in tumour progression
- (2011) C-J Chang et al. BRITISH JOURNAL OF CANCER
- ALDH1A1 Is a Novel EZH2 Target Gene in Epithelial Ovarian Cancer Identified by Genome-Wide Approaches
- (2011) H. Li et al. Cancer Prevention Research
- Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker
- (2011) Masashi Takawa et al. CANCER SCIENCE
- Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase
- (2011) Assia Derfoul et al. CARCINOGENESIS
- Polycomb genes and cancer: Time for clinical application?
- (2011) Francesco Crea et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor
- (2011) B Testoni et al. ONCOGENE
- Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
- (2011) Michiel Smits et al. PLoS One
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) B. Escudier et al. ANNALS OF ONCOLOGY
- Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
- (2010) Nina Wagener et al. BMC CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3
- (2010) Ji-Won Jung et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2
- (2010) Daisy PF Tsang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Epidemiology and risk factors for kidney cancer
- (2010) Wong-Ho Chow et al. Nature Reviews Urology
- Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
- (2009) Stefan Hinz et al. JOURNAL OF UROLOGY
- Theenhancer of zeste homolog 2gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells
- (2008) Nina Wagener et al. INTERNATIONAL JOURNAL OF CANCER
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
- (2008) S. Varambally et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started